Dermocosmetic cream for facial redness in rosacea
Part of Heart & circulation, Skin clinical trials.
This study tests a special cream to reduce facial redness caused by rosacea, either alone or combined with laser treatment. It aims to help people with persistent redness and visible blood vessels on their face.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with moderate to severe rosacea (redness and visible blood vessels on face)
- Willing to consider or undergo laser treatment for rosacea
- Not pregnant or planning to become pregnant during the study
- No other skin conditions in the treatment area (face)
- Not using other anti-redness products on your face during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests using radiofrequency microneedling, a treatment that uses tiny needles and heat, to improve rosacea symptoms like redness and bumps. It may help if you have mild to moderate rosacea.
This trial tests a small device worn on your ear that sends gentle electrical signals to a nerve, aiming to reduce facial redness and flushing from rosacea. The device may help calm the inflammation that causes rosacea symptoms.
This study tests a new facial cream to reduce redness and bumps caused by rosacea, a common skin condition. The cream may help calm inflammation and improve the appearance of affected areas on the face.
This study tests if creams containing two antidepressants (imipramine and amitriptyline) can reduce skin redness caused by UV light in people with rosacea. It compares how the creams affect redness to see if they could be a new treatment option.
This trial tests a product to reduce facial redness and flushing in people with mild sensitive skin. It uses a short infrared light exposure to induce redness and measure improvement.
This trial tests a B5 balm (CICAPLAST BAUME B5+) to see how well it helps people with rosacea and sensitive skin. It aims to reduce redness and improve skin comfort.
Hear when a new Rosacea, Erythematotelangiectatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.